Dr. Pegram on Sequencing Therapies in HER2-Positive Breast Cancer

Dr. Pegram on Sequencing Therapies in HER2-Positive Breast Cancer

ICAHO20 - ASCO Direct™ Highlight. Dr. Mark Pegram - Sequencing Therapies in Metastatic Breast CancerПодробнее

ICAHO20 - ASCO Direct™ Highlight. Dr. Mark Pegram - Sequencing Therapies in Metastatic Breast Cancer

Dr. Pegram on Challenges Facing the Treatment of HER2-Positive Breast CancerПодробнее

Dr. Pegram on Challenges Facing the Treatment of HER2-Positive Breast Cancer

ICAHO19 - Breast cancer session: Sequencing therapies in metastatic breast cancerПодробнее

ICAHO19 - Breast cancer session: Sequencing therapies in metastatic breast cancer

Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast CancerПодробнее

Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast Cancer

Dr. Pegram on Neoadjuvant Treatments for HER2-Postive Breast CancerПодробнее

Dr. Pegram on Neoadjuvant Treatments for HER2-Postive Breast Cancer

Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast CancerПодробнее

Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast Cancer